Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China · Delayed Price · Currency is CNY 5.01
+0.12 (2.45%)
At close: Oct 23, 2026
SHA:688373 Market Cap
SHA:688373 has a market cap or net worth of 3.29 billion as of October 23, 2026. It is the 14,619th most valuable company in the world and the 3,940th biggest in China. Its market cap has decreased by 35.04% in one year.
Market Cap
3.29B
Enterprise Value
3.25B
Revenue
164.33M
Global Rank
Country Rank
#3,940 China
PE Ratio
n/a
ChartMarket Cap Chart
Since August 5, 2022, SHA:688373's market cap has decreased from 7.13B to 3.29B, a decrease of -53.88%. That is a compound annual growth rate of -16.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.29B | -16.97% |
| Dec 31, 2025 | 3.96B | 22.34% |
| Dec 31, 2024 | 3.24B | -24.35% |
| Dec 29, 2023 | 4.28B | -26.30% |
| Dec 30, 2022 | 5.81B | -18.57% |
| Aug 5, 2022 | 7.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Starry Pharmaceutical | 3.50B |
| Shenzhen Neptunus Bioengineering | 3.50B |
| ChengDu ShengNuo Biotec | 3.42B |
| PKU HealthCare Corp.,Ltd. | 3.40B |
| Qianjiang Yongan Pharmaceutical | 3.26B |
| Shaanxi Kanghui Pharmaceutical | 3.26B |
| Harbin Medisan Pharmaceutical | 3.26B |
| Huaren Pharmaceutical | 3.25B |